Relation between inflammatory bowel disease, depression, and inpatient outcomes in the United States

Hassam Ali1, Rahul Pamarthy1, Nicole Leigh Bolick2

  • 1Department of Internal Medicine, East Carolina University/Vidant Medical Center, Greenville, North Carolina.

Proceedings (Baylor University. Medical Center)
|May 6, 2022
PubMed

Insights

Depression complicates inflammatory bowel disease (IBD) care, increasing hospital length of stay for ulcerative colitis (UC) and Crohn's disease (CD) patients. However, depression was linked to lower overall inpatient costs in IBD.

Area of Science:

  • Gastroenterology
  • Psychiatry
  • Health Services Research

Background:

  • The interplay between inflammatory bowel disease (IBD) and depression is complex and understudied in inpatient settings.
  • Previous research has not specifically examined the impact of depression on ulcerative colitis (UC) and Crohn's disease (CD) within the US inpatient population.

Purpose of the Study:

  • To investigate the effect of depression on hospital length of stay (LOS), costs, and mortality in hospitalized patients with UC and CD.
  • To compare the outcomes between UC and CD patients with and without depression.

Main Methods:

  • Retrospective analysis of inpatient data from the National Inpatient Sample database (2016-2019).
  • Inclusion criteria: patients admitted with UC or CD.
  • Primary outcomes: LOS, costs, and mortality. Secondary outcomes: comparison between UC and CD.

Main Results:

  • Depression was present in 13.4% of UC patients and 14.9% of CD patients.
  • Patients with depression experienced longer LOS in both UC and CD cohorts (P < 0.001).
  • Depression was associated with lower inpatient hospital costs across IBD (P < 0.001), but higher costs in CD vs. UC subgroups ($17,974 difference, P < 0.001).
  • Depression did not significantly increase mortality but did increase LOS, with a more pronounced effect in CD patients compared to UC patients.

Conclusions:

  • Depression significantly increases hospital LOS for IBD patients, particularly those with Crohn's disease.
  • While depression is linked to increased LOS, it is paradoxically associated with lower overall inpatient costs for IBD patients.
  • White women exhibit a higher prevalence of depression within the IBD population.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
436
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
358
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
414
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
208
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
548
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
388